April 2022 – Medialis

Linkedin Made by Medialis Prescriber Regulator

Development of a Definition for Medical Affairs Using the Jandhyala Method for Observing Consensus Opinion Among Medical Affairs Pharmaceutical Physicians

April 13, 20220

Background: There is currently no standard definition of medical affairs, despite its increasing importance to the pharmaceutical industry. The evolution of medical affairs necessitated the development of a standardised definition to guide policy and practice to ensure that patients’ interests remain central amid shifts that have, in the past, created fertile ground for ethical violations....

Made by Medialis Regulator

The Jandhyala Method: A novel method for observing proportional group awareness and consensus of items arising from list-generating questioning

April 12, 20220

We’re celebrating a birthday here at @medialis: the #jandhyalamethod is 2 years old today. Published online in 2020, it has been used to delivered 6 important pieces of original research in #medicalaffairs and #realworldevidence in #rarediseases and a broader #construct measurement. In delivering the first disease-specific #qol instrument for #longcovid, the #jandhyalamethod operationalised #neutraltheory to...

Made by Medialis Patient

Angelman Syndrome

April 12, 20220

At Medialis Ltd our focus is rare diseases. Our third #RareDiseaseSpotlight in the 2022 series is Angelman syndrome, a rare neurodevelopmental disorder. It is characterised by severe learning difficulties, ataxia, a seizure disorder with a characteristic EEG, subtle dysmorphic facial features, and a happy, sociable disposition. With the care and support from patient organizations Angelman Syndrome Foundation, Foundation for Angelman Syndrome...